Total Payments
$1.3M
2024 Payments
$21.68
Companies
11
Transactions
294
Medicare Patients
562
Medicare Billing
$10.8M
Payment Breakdown by Category
Other$736,775 (58.1%)
Consulting$480,135 (37.9%)
Travel$45,468 (3.6%)
Food & Beverage$5,744 (0.5%)
Education$0.35 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $480,135 | 26 | 37.9% |
| Grant | $465,952 | 4 | 36.7% |
| Honoraria | $227,899 | 115 | 18.0% |
| Travel and Lodging | $45,468 | 43 | 3.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,924 | 22 | 3.4% |
| Food and Beverage | $5,744 | 83 | 0.5% |
| Education | $0.35 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $1.2M | 272 | $0 (2023) |
| Vertical Pharmaceuticals, LLC | $15,050 | 2 | $0 (2020) |
| Horizon Pharma plc | $3,613 | 10 | $0 (2018) |
| Allergan, Inc. | $310.98 | 3 | $0 (2022) |
| MERZ NORTH AMERICA, INC. | $155.47 | 1 | $0 (2017) |
| Genentech USA, Inc. | $143.65 | 1 | $0 (2022) |
| Galderma Laboratories, L.P. | $143.48 | 1 | $0 (2020) |
| Stryker Corporation | $84.03 | 1 | $0 (2019) |
| Amgen Inc. | $21.68 | 1 | $0 (2024) |
| Lilly USA, LLC | $20.10 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.68 | 1 | Amgen Inc. ($21.68) |
| 2023 | $210,066 | 41 | Horizon Therapeutics plc ($210,066) |
| 2022 | $235,450 | 41 | Horizon Therapeutics plc ($235,159) |
| 2021 | $329,138 | 53 | Horizon Therapeutics plc ($329,138) |
| 2020 | $371,595 | 99 | Horizon Therapeutics plc ($356,238) |
| 2019 | $118,062 | 47 | Horizon Therapeutics plc ($117,978) |
| 2018 | $2,377 | 9 | Horizon Pharma plc ($2,377) |
| 2017 | $1,412 | 3 | Horizon Pharma plc ($1,236) |
All Payment Transactions
294 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/21/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Consulting Fee | Cash or cash equivalent | $21,200.00 | General |
| Category: TEPEZZA | ||||||
| 08/31/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $6,250.00 | General |
| Category: TEPEZZA | ||||||
| 08/31/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Travel and Lodging | In-kind items and services | $652.98 | General |
| Category: TEPEZZA | ||||||
| 08/31/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Travel and Lodging | In-kind items and services | $485.19 | General |
| Category: TEPEZZA | ||||||
| 08/31/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $136.44 | General |
| Category: TEPEZZA | ||||||
| 08/28/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: TEPEZZA | ||||||
| 08/24/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: TEPEZZA | ||||||
| 08/23/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $6,250.00 | General |
| Category: TEPEZZA | ||||||
| 08/23/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $119.23 | General |
| Category: TEPEZZA | ||||||
| 08/22/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $937.50 | General |
| Category: TEPEZZA | ||||||
| 07/26/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $400.00 | General |
| Category: TEPEZZA | ||||||
| 06/20/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $1,875.00 | General |
| Category: TEPEZZA | ||||||
| 06/20/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $200.00 | General |
| Category: TEPEZZA | ||||||
| 05/17/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $1,875.00 | General |
| Category: TEPEZZA | ||||||
| 03/24/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Grant | Cash or cash equivalent | $111,285.34 | General |
| Category: TEPEZZA | ||||||
| 02/08/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $3,125.00 | General |
| Category: TEPEZZA | ||||||
| 02/08/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $117.96 | General |
| Category: TEPEZZA | ||||||
| 02/04/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $8,437.50 | General |
| Category: TEPEZZA | ||||||
| 02/04/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Travel and Lodging | Cash or cash equivalent | $663.42 | General |
| Category: TEPEZZA | ||||||
| 02/04/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $84.99 | General |
| Category: TEPEZZA | ||||||
| 02/04/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $63.83 | General |
| Category: TEPEZZA | ||||||
| 02/04/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: TEPEZZA | ||||||
| 02/03/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $3,438.00 | General |
| Category: TEPEZZA | ||||||
| 02/03/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: TEPEZZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 138 | 16,208 | $10.2M | $4.1M |
| 2022 | 11 | 253 | 14,412 | $9.7M | $3.5M |
| 2021 | 6 | 96 | 12,826 | $6.6M | $3.2M |
| 2020 | 6 | 75 | 300 | $82,080 | $14,574 |
Total Patients
562
Total Services
43,746
Medicare Billing
$10.8M
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3241 | Injection, teprotumumab-trbw, 10 mg | Office | 2023 | 23 | 15,800 | $10.1M | $4.0M | 40.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 28 | 134 | $99,800 | $15,359 | 15.4% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 21 | 99 | $29,700 | $5,380 | 18.1% |
| 92285 | Photography of content of eyes | Office | 2023 | 17 | 58 | $6,960 | $1,016 | 14.6% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 16 | 32 | $14,100 | $814.84 | 5.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 11 | 11 | $3,168 | $770.79 | 24.3% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 22 | 74 | $4,440 | $38.16 | 0.9% |
| J3241 | Injection, teprotumumab-trbw, 10 mg | Office | 2022 | 25 | 13,800 | $9.5M | $3.5M | 36.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 38 | 108 | $43,200 | $11,289 | 26.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 14 | 50 | $35,000 | $6,357 | 18.2% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2022 | 25 | 105 | $31,500 | $5,868 | 18.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 29 | 29 | $14,500 | $5,303 | 36.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 22 | 55 | $27,500 | $3,088 | 11.2% |
| 92285 | Photography of content of eyes | Office | 2022 | 25 | 105 | $12,600 | $1,850 | 14.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 20 | 20 | $5,760 | $1,432 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 14 | 15 | $3,260 | $690.40 | 21.2% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2022 | 16 | 22 | $6,600 | $421.82 | 6.4% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2022 | 25 | 103 | $6,180 | $54.29 | 0.9% |
| J3241 | Injection, teprotumumab-trbw, 10 mg | Office | 2021 | 14 | 12,450 | $6.5M | $3.1M | 48.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 24 | 92 | $36,800 | $10,255 | 27.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 14 | 71 | $35,500 | $4,782 | 13.5% |
| 92060 | Measurement of eye muscles to detect deviation of eyeball | Office | 2021 | 15 | 73 | $21,900 | $4,254 | 19.4% |
| 92285 | Photography of content of eyes | Office | 2021 | 15 | 73 | $8,760 | $1,313 | 15.0% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2021 | 14 | 67 | $4,020 | $37.08 | 0.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 13 | 55 | $22,000 | $6,305 | 28.7% |
About Raymond Douglas, MD, PHD
Raymond Douglas, MD, PHD is a Ophthalmology healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124041959.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Raymond Douglas, MD, PHD has received a total of $1.3M in payments from pharmaceutical and medical device companies, with $21.68 received in 2024. These payments were reported across 294 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($480,135).
As a Medicare-enrolled provider, Douglas has provided services to 562 Medicare beneficiaries, totaling 43,746 services with total Medicare billing of $10.8M. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Beverly Hills, CA
- Active Since 07/25/2006
- Last Updated 07/27/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1124041959
Products in Payments
- TEPEZZA (Drug) $1.1M
- KRYSTEXXA (Biological) $27,300
- TEPEZZA (Biological) $15,905
- TEPRO (Drug) $3,613
- BOTOX COSMETIC (Biological) $163.28
- Xeomin (Biological) $155.47
- VUITY (Drug) $147.70
- Erivedge (Biological) $143.65
- SPIROX - LATERA (Device) $84.03
- TRULICITY (Drug) $20.10
- (820) Cholbam (Drug) $0.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Beverly Hills
Stuart Stoll, Md, MD
Ophthalmology — Payments: $1.2M
Ophthalmology $1.2M
Dr. Michael Javaheri, M.d, M.D
Ophthalmology — Payments: $453,983
Ophthalmology $453,983
Kerry Assil, M.d, M.D
Ophthalmology — Payments: $378,371
Ophthalmology $378,371
Afshin Khodabakhsh, Md, MD
Ophthalmology — Payments: $158,563
Ophthalmology $158,563
Christopher Zoumalan, M.d, M.D
Ophthalmology — Payments: $156,708
Ophthalmology $156,708
Dr. Jillian Chong, M.d, M.D
Ophthalmology — Payments: $58,972
Ophthalmology $58,972